Clinical Trial Update: Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial [NA]

View source ↗

Summary

A completed randomized feasibility trial evaluating anti-Factor Xa monitoring for anticoagulation in patients with left-sided heart failure undergoing left vent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Assist Device Infection
• Left-sided Heart Failure

Snippet

Sponsor: Washington University School of Medicine | Conditions: Left Sided Heart Failure, Left Ventricular Assist Device | NA | Status: COMPLETED | Results posted: 2020-02-25